PROCEPT BioRobotics Market Sentiment

PROCEPT BioRobotics Corp

PRCTNASDAQ

Trade with Public

$17.90

-0.01-0.06%

마지막 업데이트: Oct 8, 4:00 PM

$17.90

-0.01-0.06%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

PROCEPT BioRobotics Market Sentiment - Benzinga

PROCEPT BioRobotics Market Sentiment

Market sentiment signals for PROCEPT BioRobotics (PRCT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▼ 13.4% short float

Options Flow▲ 0.01 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Overweight

15 analysts

Options Flow (P/C)

0.01

More calls — Bullish

203 calls · 2 puts

Avg Consensus PT

$34

+90.9%

Highest Price Target

$95

+430.7%

Jefferies

Lowest Price Target

$20

+11.7%

UBS

Short Interest

13.4%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 7, 2026	Barclays	Christopher Pasquale—	+67.6%	$30	Initiate	Overweight
Aug 5, 2026	TD Cowen	Joshua Jennings—	+56.4%	$34 → $28	Maintained	Buy
Aug 5, 2026	Piper Sandler	Matt O'Brien—	+39.7%	$35 → $25	Maintained	Overweight
Aug 5, 2026	Evercore ISI Group	Vijay Kumar—	+28.5%	$30 → $23	Maintained	Outperform
Aug 5, 2026	William Blair	Brandon Vazquez—	—	—	Downgrade	Outperform→Market Perform
Jul 28, 2026	UBS	Danielle Antalffy—	+11.7%	$20	Assumes	Buy→Neutral
Jul 6, 2026	Truist Securities	Richard Newitter—	+39.7%	$30 → $25	Downgrade	Buy→Hold
Jun 24, 2026	Evercore ISI Group	Vijay Kumar—	+67.6%	$30	Initiate	Outperform
Jun 11, 2026	Leerink Partners	Mike Kratky—	+62.0%	$31 → $29	Downgrade	Outperform→Market Perform
Apr 30, 2026	Piper Sandler	Matt O'Brien—	+95.5%	$28 → $35	Maintained	Overweight
Mar 6, 2026	Baird	David Rescott—	+67.6%	$30	Initiate	Neutral
Mar 2, 2026	Truist Securities	Richard Newitter—	+67.6%	$47 → $30	Maintained	Buy
Feb 26, 2026	Leerink Partners	Mike Kratky—	+67.6%	$55 → $30	Maintained	Outperform
Feb 26, 2026	TD Cowen	Joshua Jennings—	+89.9%	$50 → $34	Maintained	Buy
Feb 26, 2026	Oppenheimer	Suraj Kalia—	—	—	Downgrade	Outperform→Perform
Feb 26, 2026	Piper Sandler	Matt O'Brien—	+56.4%	$50 → $28	Maintained	Overweight
Feb 26, 2026	Wells Fargo	Nathan Treybeck—	+89.9%	$51 → $34	Maintained	Overweight
Feb 26, 2026	B of A Securities	Craig Bijou—	+11.7%	$38 → $20	Downgrade	Neutral→Underperform
Dec 18, 2025	Truist Securities	Richard Newitter—	+162.6%	$50 → $47	Maintained	Buy
Dec 12, 2025	UBS	Danielle Antalffy—	+246.4%	$62	Initiate	Buy
Dec 8, 2025	B of A Securities	Craig Bijou—	+112.3%	$55 → $38	Downgrade	Buy→Neutral
Dec 2, 2025	Morgan Stanley	Patrick Wood—	+184.9%	$56 → $51	Maintained	Overweight
Nov 5, 2025	TD Cowen	Joshua Jennings—	+179.3%	$85 → $50	Maintained	Buy
Nov 5, 2025	Piper Sandler	Matt O'Brien—	+179.3%	$55 → $50	Maintained	Overweight
Nov 5, 2025	Wells Fargo	Nathan Treybeck—	+184.9%	$58 → $51	Maintained	Overweight